Sigyn Therapeutics Gross Margin Growth & History (SIGY)

Sigyn Therapeutics's gross margin was 75.12% for fiscal 2019.

View full Sigyn Therapeutics company overview

Sigyn Therapeutics annual gross margin history

Sigyn Therapeutics annual gross margin

Fiscal yearPeriod endedGross marginChange (percentage points)
20192019-12-3175.12%+9.38 pp
20182018-12-3165.74%−0.26 pp
20152015-12-3166.00%+24.51 pp
20142014-12-3141.49%

Sigyn Therapeutics gross margin trends

Across the available reported history, Sigyn Therapeutics's gross margin increased from 65.74% to 75.12%, a change of +9.38 percentage points. The latest reported quarter, Q3 2020, shows 53.08%.

About the metric

What gross margin means

Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.

Calculation and source

How gross margin is calculated

TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Sigyn Therapeutics filings at SEC.gov ↗